Skip to main content
. 2024 May 21;19(5):e0303557. doi: 10.1371/journal.pone.0303557

Table 1. Univariable analysis of the differences in sepsis and non-sepsis groups.

Variables sepsis (n = 268) Non-sepsis (n = 1651) Z χ2 P
Age (year) 70 (59, 78) 70 (61, 79) -1.331 0.183
Male in Gender, n (%) 100 (37.31) 596 (36.10) 0.701
ALB (g/L) 31.4 (28.6, 34.3) 37.1 (33.6, 40.2) -12.209 <0.001
CRP (mg/L) 111.63 (43.33, 184.63) 13.59 (2.5, 58.8) -14.488 <0.001
PCT (ng/ml) 3.265 (0.771, 13.25) 0.166 (0.061, 0.566) -16.445 <0.001
HbA1c (%) 7.7 (6.5, 9.8) 7 (6.2, 8.7) -4.326 <0.001
WBC (109/L) 12.04 (8.76, 17.56) 7.56 (5.87, 10.77) -12.078 <0.001
LEU positive in urine, n (%) 211 (81.78) 1171 (73.51) 8.035 0.005
Glucose in urine n (%) 19.105 0.002
4+ 61 (22.76) 252 (15.52)
3+ 29 (10.82) 142 (8.74)
2+ 12 (4.48) 79 (4.86)
1+ 27 (10.07) 106 (6.53)
± 6 (2.24) 67 (4.13)
- 133 (49.63) 978 (60.22)
Complications of diabetes, n (%) 48 (17.91) 320 (19.38) 0.322 0.570
Hypertension, n (%) 160 (59.7) 1084 (65.66) 3.587 0.058
Malignant tumor, n (%) 25 (9.33) 194 (11.75) 1.338 0.247
Coronary heart disease, n (%) 39 (14.55) 354 (21.44) 6.72 0.010
Catheterization, n (%) 23 (8.58) 74 (4.48) 8.076 0.004
Glucocorticoid use, n (%) 70 (26.12) 241 (14.6)   22.541 <0.001

ALB, albumin; CRP, C-reactive protein; PCT, procalcitonin; HbA1c, glycated haemoglobin; WBC, white blood cell count; LEU, leukocyte; glucose in urine 4+, glucose concentration ≥2000 mg/dL; 3+, 500–1999 mg/dL; 2+, 250–499 mg/dL; 1+, 100–249 mg/dL; ±, 50–99 mg/dL; -, < 50 mg/dL.